SB 206553, a putative 5-HT_2C inverse agonist, attenuates methamphetamine-seeking in rats

Keyphrases

• Methamphetamine 100%
• 5-HT2C 100%
• Inverse Agonist 100%
• 5-HT2C Receptor 41%
• Mirtazapine 25%
• SB242084 25%
• Cue Reactivity 25%
• Motor Function 16%
• Motor Activity 16%
• 5-HT2C Antagonist 16%
• Inverse Agonism 16%
• Rodent Models 8%
• Pharmacotherapy 8%
• Therapeutic Target 8%
• FDA-approved Drugs 8%
• Antagonism 8%
• High Dose 8%
• Psychostimulants 8%
• Receptor-mediated 8%
• Substance Abuse 8%
• Constitutively Active 8%
• 5-hydroxytryptamine 8%
• Socioeconomic Burden 8%
• Observed Effects 8%
• Self-administer 8%
• Atypical Antidepressants 8%
• Seeking Behavior 8%
• Rearing Behavior 8%
• Methamphetamine Dependence 8%
• Psychostimulant Abuse 8%

Neuroscience

• 5-HT2C Receptor 100%
• Inverse Agonist 100%
• Behavior (Neuroscience) 80%
• Mirtazapine 60%
• Psychostimulant 40%
• 5-HT2C Antagonists 40%
• Inverse Agonism 40%
• Antidepressant 20%
• Methamphetamine Dependence 20%